Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Scales Back LABA Safety Relabeling To Address Physician Worries

Jun 07 2010

• By The Pink Sheet

Related Content

Amgen Pays Array $60 Million Upfront For Its Phase One Type 2 Diabetes Compound

Dec 15 2009

Cosmeceutical Claims May Be Headed Into FDA's Radar

Aug 10 2009

FDA Enforcement Stance Turned Aggressive Months Before Aug. 6 Initiatives

Aug 31 2009

FDA Looms Large As Bayer Surrenders One A Day Selenium Prostate Claims

Jun 29 2009

PBM Power Behind Pharmacogenomics: CVS Caremark Launching Program

Nov 16 2009

Alnylam Set To Bring 3rd Program Into Clinic; Continue Progress Of Other Two

Nov 16 2009

Benlysta Back In The Spotlight With BLISS-76, But Second Phase III Still May Not Be Enough To Support Some Claims

Nov 02 2009

Litigation In Brief

Aug 24 2009

2009 Is ImmunoGen’s Make-Or-Break Year

Mar 05 2009

Comparative Effectiveness Reaches Into Drug Reviews, FDA Documents Show

Dec 01 2009

Greece Lowers Drug Prices By Up To 27 Percent

May 05 2010

Proposals For Drug Pricing Reforms In Germany Come Under Heavy Political And Industry Pressure

May 05 2010

Wyeth Nutrition Posts Double-Digit Growth; PSE Harms Consumer Unit Sales

Apr 24 2006

CMS Open To Discussion On Manufacturer Payment Time For Part D Discounts

May 31 2010

FDA Agenda Pushes Back Sunscreen Rule, Cough/Cold Dosing Proposal

May 17 2010

IOM Proposal Could Open Door For Biomarkers In Supplement Research

May 17 2010

Sponsors Caution Against Premature Expanded Access For Novel HCV Drugs

May 01 2010

With Diminishing Cash, Aryx Seeks Pharma Partners For Mid-Stage Assets

May 13 2010

Patent Office Would Get Ability To Set Fees Under House Bill; PTO To Allow Applicants To Fast Track One Application By Dropping Another

May 24 2010

Respiratory Generics: Big Potential But A Tough Market To Crack

May 24 2010

FTC Prioritizes Food Advertising Investigations Over Supplement Claims

May 03 2010

R&D Swapping: AstraZeneca Lures Mackay From Pfizer To Head Global R&D

May 26 2010

Trade Groups Defend Qualified Health Claims Following Critical GAO Report

Oct 20 2008

FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data

Sep 15 2008

Novo Nordisk Licenses GKA Program To Innovator TransTech

Feb 22 2007

Sunscreen Proposed Rule May Create UVA Protection Marketing Opportunity

Aug 27 2007

FDA Rules On INDs May Embolden More Patients To Ask For Trial Drugs

Aug 17 2009

Sponsors Can Charge For IND Drugs If They Offer "Significant Advantage"

Aug 17 2009

Dermatologists Expect FDA Sunscreen Rule "Soon," End Product Seal Program

Dec 07 2009

Korean Government Announces Joint Fund To Beef Up Local Pharma Industry

Feb 10 2010

Roche To File NDA For T-DM1 This Year

Apr 15 2010

Would AstraZeneca Be Better Off If Rezield Had Gotten A Harsher FDA Letter?

Jun 07 2010

LABA Label Changes Could Reinvigorate Single-Ingredient Products

Jun 07 2010

LABA Safety Studies, REMS Are Next Topics For Sponsors, FDA After Relabeling

Jun 07 2010

Motavizumab's Data Integrity Worries Grow As FDA Shows Interest In Lawsuit

Jun 07 2010

Rezield Needs Advantage Over Synagis, Advisory Cmte. Tells MedImmune

Jun 07 2010

Clinical Trials Or Observational Studies for Asthma? FDA Advisory Panels Can't Agree

Mar 12 2010

Clinical Trials Or Observational Studies For Asthma? FDA Advisory Panels Can't Agree

Mar 22 2010

Raising The Bar For Anticoagulants? Warfarin Genotype Results Announced

Mar 22 2010

Financial Incentives Seen As A Path To Resurgence Of Antibiotics

Apr 26 2010

Data Leave Holes In Cosmeceutical Vitamin Claims - Study

Apr 12 2010

CTI's Pixuvri Strategy After FDA Rejection: Pursue Expanded Access, Start Combination Trial

Apr 09 2010

New Tactic In ANDA Litigation: Novo Blocks Generic Prandin By Changing Its Patent Use Code

Apr 19 2010

Valuation Watch: As Biopharma IPOs Return, Does Value?

May 01 2010

Samsung Group Set To Enter Biosimilars Market With $1.9 Billion Investment

May 17 2010

FDA Okays Amgen's Prolia, But With Hefty Post-Marketing Requirements In Tow

Jun 01 2010

Motavizumab Advisory Committee To Consider Possible Study Bias

Jun 01 2010

Korea's Samsung Electronics On Manhunt For Biosimilar Talent As Local Companies Keep Wary Eye On Competition

Mar 26 2010

GlaxoSmithKline Hires Former FDA Top Lawyer Dan Troy As General Counsel

Jul 28 2008

Kyowa Hakko’s Parkinson’s Drug Is Not Approvable – U.S. FDA

Feb 28 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window